Dr. Talboy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1365 Clifton Rd NE
Atlanta, GA 30322Phone+1 404-778-8570
Summary
- Dr. Amy Talboy is a pediatrician in Atlanta, GA. She received her medical degree from Eastern Virginia Medical School, and completed pediatric internship and residency at Children's Hospital of the Kings Daughters, Norfolk, VA. Fellowship training in Neurodevelopment Disabilities and Developmental-Behavioral Pediatrics was completed at Kennedy Krieger Institute, Johns Hopkins University School of Medicine. Dr. Talboy is an Assistant Professor, Departments of Human Genetics and Pediatrics, Emory University School of Medicine. She is on staff with Emory Healthcare as well as Children's Healthcare of Atlanta. Her clinical roles include director, Down syndrome, Fragile X syndrome and the eXtraordinarY (sex chromosome aneuloploidy) Clinics at Emory. She consults on a variety of cases within the Division of Human Genetics, and has been site PI on numerous clinical trials. She is an active member of the Georgia Chapter of the American Academy of Pediatrics, including Co-Chair Committee on Children with Disabilities.
Education & Training
- Johns Hopkins UniversityFellowship, Neurodevelopmental Disabilities, 1990 - 1993
- Eastern Virginia Medical SchoolResidency, Pediatrics, 1987 - 1990
- Eastern Virginia Medical SchoolResidency, Pediatrics, 1983 - 1987
- Eastern Virginia Medical SchoolClass of 1987
Certifications & Licensure
- GA State Medical License 1993 - 2025
- MD State Medical License 1990 - 1993
- American Board of Pediatrics Pediatrics
- American Board of Psychiatry and Neurology Neurodevelopmental Disabilities
Clinical Trials
- Congenital Heart Disease: Impact on Learning and Development in Down Syndrome (CHILD-DS) Start of enrollment: 2022 May 01
- Down Syndrome Clinical Trials - Study of Alzheimer's Disease in Down Syndrome Start of enrollment: 2019 Jun 30
- Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS Start of enrollment: 2018 Nov 09
- Join now to see all
Publications & Presentations
PubMed
- 14 citationsCross-Sectional Exploration of Plasma Biomarkers of Alzheimer’s Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Re...James Hendrix, David C. Airey, Angela Britton, Anna D. Burke, George T. Capone
Journal of Clinical Medicine. 2021-04-28 - 11 citationsRare sex chromosome variation 48,XXYY: An integrative reviewAmy Blumling, Kristy K. Martyn, Amy Talboy, Sharron Close
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics. 2020-06-01 - 33 citationsSoy-Based Infant Formula is Associated with an Increased Prevalence of Comorbidities in Fragile X SyndromeCara J. Westmark, Chad Kniss, Emmanuel Sampene, Angel Wang, Amie Milunovich
Nutrients. 2020-10-14
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: